Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — January 2026

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

Natera, Inc. (NTRA)

Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Jan 29, 2026
Sale
Shares
876
Price
$230.92
Total Value
$202.29K
Shares Held After
59,059
% of Holdings
1.5%

Natera, Inc. (NTRA)

Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Jan 29, 2026
Sale
Shares
991
Price
$229.94
Total Value
$227.87K
Shares Held After
59,935
% of Holdings
1.6%

ELUTIA INC. (ELUT)

NEELS GUIDO J — Director
Jan 29, 2026
Purchase
Shares
15,000
Price
$1.06
Total Value
$15.90K
Shares Held After
98,750
% of Holdings
15.2%

IRIDEX CORP (IRIX)

Dizon Romeo R — Chief Financial Officer
Jan 29, 2026
Purchase
Shares
1,101
Price
$1.44
Total Value
$1.59K
Shares Held After
112,690
% of Holdings
1.0%

InspireMD, Inc. (NSPR)

Gleason Shane Thomas — Chief Commercial Officer
Jan 28, 2026
Sale
Shares
12,395
Price
$1.65
Total Value
$20.46K
Shares Held After
1,149,077
% of Holdings
1.1%
Jan 28, 2026
Sale
Shares
664
Price
$19.05
Total Value
$12.65K
Shares Held After
393,147
% of Holdings
0.2%
Jan 28, 2026
Sale
Shares
5,860
Price
$18.61
Total Value
$109.05K
Shares Held After
393,811
% of Holdings
1.5%

MASIMO CORP (MASI)

Sampath Anand — EVP, Ops & Clinical Research
Jan 28, 2026
Sale
Shares
196
Price
$138.09
Total Value
$27.07K
Shares Held After
40,909
% of Holdings
0.5%

MASIMO CORP (MASI)

Sampath Anand — EVP, Ops & Clinical Research
Jan 28, 2026
Sale
Shares
6,560
Price
$137.22
Total Value
$900.16K
Shares Held After
41,105
% of Holdings
13.8%

MASIMO CORP (MASI)

Sampath Anand — EVP, Ops & Clinical Research
Jan 28, 2026
Sale
Shares
11,924
Price
$136.56
Total Value
$1.63M
Shares Held After
47,665
% of Holdings
20.0%

Contineum Therapeutics, Inc. (CTNM)

Watkins Tim — CMO & Head of Development
Jan 28, 2026
Sale
Shares
811
Price
$14.48
Total Value
$11.75K
Shares Held After
0
% of Holdings
100.0%

Contineum Therapeutics, Inc. (CTNM)

Watkins Tim — CMO & Head of Development
Jan 28, 2026
Sale
Shares
2,800
Price
$14.09
Total Value
$39.44K
Shares Held After
811
% of Holdings
77.5%
Jan 28, 2026
Sale
Shares
191
Price
$6.59
Total Value
$1.26K
Shares Held After
17,476
% of Holdings
1.1%
Jan 28, 2026
Sale
Shares
30,526
Price
$66.06
Total Value
$2.02M
Shares Held After
16,055,469
% of Holdings
0.2%
Jan 28, 2026
Sale
Shares
102,474
Price
$65.41
Total Value
$6.70M
Shares Held After
16,085,995
% of Holdings
0.6%
Jan 28, 2026
Sale
Shares
7,619
Price
$66.06
Total Value
$503.31K
Shares Held After
8,941,533
% of Holdings
0.1%
Jan 28, 2026
Sale
Shares
25,631
Price
$65.41
Total Value
$1.68M
Shares Held After
8,949,152
% of Holdings
0.3%
Jan 28, 2026
Sale
Shares
3,648
Price
$237.66
Total Value
$866.99K
Shares Held After
213,180
% of Holdings
1.7%

Natera, Inc. (NTRA)

Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Jan 28, 2026
Sale
Shares
1,176
Price
$237.44
Total Value
$279.23K
Shares Held After
60,926
% of Holdings
1.9%

Natera, Inc. (NTRA)

Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Jan 28, 2026
Sale
Shares
1,237
Price
$237.66
Total Value
$293.99K
Shares Held After
62,102
% of Holdings
2.0%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Jan 28, 2026
Sale
Shares
1,200
Price
$237.66
Total Value
$285.19K
Shares Held After
142,486
% of Holdings
0.8%

Natera, Inc. (NTRA)

Fesko John — PRESIDENT, CHIEF BUS. OFFICER
Jan 28, 2026
Sale
Shares
928
Price
$237.66
Total Value
$220.55K
Shares Held After
175,540
% of Holdings
0.5%

Natera, Inc. (NTRA)

Sheena Jonathan — Director
Jan 28, 2026
Sale
Shares
191
Price
$237.66
Total Value
$45.39K
Shares Held After
263,596
% of Holdings
0.1%

Natera, Inc. (NTRA)

RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER
Jan 28, 2026
Sale
Shares
1,000
Price
$237.66
Total Value
$237.66K
Shares Held After
225,147
% of Holdings
0.4%
Jan 28, 2026
Sale
Shares
46,000
Price
$2.17
Total Value
$99.81K
Shares Held After
989,925
% of Holdings
4.4%

ELUTIA INC. (ELUT)

NEELS GUIDO J — Director
Jan 28, 2026
Purchase
Shares
15,000
Price
$1.06
Total Value
$15.90K
Shares Held After
83,750
% of Holdings
17.9%

Karyopharm Therapeutics Inc. (KPTI)

Abate Kristin — Chief Accounting Officer
Jan 28, 2026
Sale
Shares
50
Price
$7.03
Total Value
$351.50
Shares Held After
22,622
% of Holdings
0.2%
Jan 28, 2026
Sale
Shares
4,968
Price
$140.24
Total Value
$696.73K
Shares Held After
556,698
% of Holdings
0.9%
Jan 28, 2026
Sale
Shares
5,032
Price
$139.54
Total Value
$702.19K
Shares Held After
561,666
% of Holdings
0.9%

NewAmsterdam Pharma Co N.V. (NAMS)

Kooij Louise Frederika — Chief Accounting Officer
Jan 28, 2026
Sale
Shares
32,612
Price
$31.80
Total Value
$1.04M
Shares Held After
24,353
% of Holdings
57.2%

Relay Therapeutics, Inc. (RLAY)

Catinazzo Thomas — Chief Financial Officer
Jan 28, 2026
Sale
Shares
1,695
Price
$8.45
Total Value
$14.32K
Shares Held After
249,301
% of Holdings
0.7%
Jan 28, 2026
Sale
Shares
2,686
Price
$8.45
Total Value
$22.70K
Shares Held After
420,047
% of Holdings
0.6%

Relay Therapeutics, Inc. (RLAY)

Rahmer Peter — Chief Corporate Development Officer
Jan 28, 2026
Sale
Shares
1,354
Price
$8.45
Total Value
$11.44K
Shares Held After
276,610
% of Holdings
0.5%

Serina Therapeutics, Inc. (SER)

Moreadith Randall — Chief Scientific Officer
Jan 28, 2026
Sale
Shares
6,500
Price
$3.57
Total Value
$23.19K
Shares Held After
0
% of Holdings
100.0%
Jan 28, 2026
Purchase
Shares
10,000
Price
$3.04
Total Value
$30.40K
Shares Held After
135,000
% of Holdings
7.4%

Acumen Pharmaceuticals, Inc. (ABOS)

Meisner Derek M — Chief Legal Officer & Corp Sec
Jan 28, 2026
Sale
Shares
2,671
Price
$3.00
Total Value
$8.02K
Shares Held After
173,999
% of Holdings
1.5%

Clene Inc. (CLNN)

Ugwumba Chidozie — 10% Owner
Jan 28, 2026
Sale
Shares
8,717
Price
$4.91
Total Value
$42.80K
Shares Held After
580,329
% of Holdings
1.5%

IRIDEX CORP (IRIX)

Dizon Romeo R — Chief Financial Officer
Jan 28, 2026
Purchase
Shares
1,300
Price
$1.46
Total Value
$1.90K
Shares Held After
111,589
% of Holdings
1.2%

InspireMD, Inc. (NSPR)

Gleason Shane Thomas — Chief Commercial Officer
Jan 27, 2026
Sale
Shares
4,781
Price
$1.66
Total Value
$7.96K
Shares Held After
1,161,472
% of Holdings
0.4%
Jan 27, 2026
Sale
Shares
2,322
Price
$240.53
Total Value
$558.51K
Shares Held After
216,828
% of Holdings
1.1%

Natera, Inc. (NTRA)

Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Jan 27, 2026
Sale
Shares
784
Price
$240.53
Total Value
$188.58K
Shares Held After
63,339
% of Holdings
1.2%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Jan 27, 2026
Sale
Shares
1,013
Price
$240.53
Total Value
$243.66K
Shares Held After
143,686
% of Holdings
0.7%

Natera, Inc. (NTRA)

Fesko John — PRESIDENT, CHIEF BUS. OFFICER
Jan 27, 2026
Sale
Shares
784
Price
$240.53
Total Value
$188.58K
Shares Held After
176,468
% of Holdings
0.4%

Natera, Inc. (NTRA)

Sheena Jonathan — Director
Jan 27, 2026
Sale
Shares
291
Price
$240.53
Total Value
$69.99K
Shares Held After
263,787
% of Holdings
0.1%

Natera, Inc. (NTRA)

RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER
Jan 27, 2026
Sale
Shares
886
Price
$240.53
Total Value
$213.11K
Shares Held After
226,147
% of Holdings
0.4%

Celcuity Inc. (CELC)

Dalvey David — Director
Jan 27, 2026
Sale
Shares
20,000
Price
$120.03
Total Value
$2.40M
Shares Held After
90,000
% of Holdings
18.2%

NewAmsterdam Pharma Co N.V. (NAMS)

Kooij Louise Frederika — Chief Accounting Officer
Jan 27, 2026
Sale
Shares
39,816
Price
$32.62
Total Value
$1.30M
Shares Held After
24,353
% of Holdings
62.0%
Jan 27, 2026
Purchase
Shares
100
Price
$57.05
Total Value
$5.71K
Shares Held After
449,944
% of Holdings
0.0%

Relay Therapeutics, Inc. (RLAY)

Catinazzo Thomas — Chief Financial Officer
Jan 27, 2026
Sale
Shares
13,820
Price
$7.62
Total Value
$105.31K
Shares Held After
250,996
% of Holdings
5.2%
Jan 27, 2026
Sale
Shares
18,895
Price
$7.62
Total Value
$143.98K
Shares Held After
422,733
% of Holdings
4.3%
Version: v26.3.23